Dexcom (DXCM) Cash from Financing Activities (2016 - 2025)
Dexcom (DXCM) has disclosed Cash from Financing Activities for 16 consecutive years, with -$1.5 billion as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities fell 95037.5% to -$1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 billion through Dec 2025, down 129.5% year-over-year, with the annual reading at -$1.7 billion for FY2025, 129.5% down from the prior year.
- Cash from Financing Activities for Q4 2025 was -$1.5 billion at Dexcom, down from -$175.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $939.5 million in Q2 2023, with the low at -$1.5 billion in Q4 2025.
- Average Cash from Financing Activities over 5 years is -$164.1 million, with a median of -$1.2 million recorded in 2022.
- The sharpest move saw Cash from Financing Activities skyrocketed 21948.84% in 2023, then crashed 95037.5% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$800000.0 in 2021, then decreased by 25.0% to -$1.0 million in 2022, then plummeted by 63090.0% to -$631.9 million in 2023, then surged by 99.75% to -$1.6 million in 2024, then plummeted by 95037.5% to -$1.5 billion in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$1.5 billion, -$175.0 million, and -$1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.